DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hee Yoon | ko |
dc.contributor.author | Sohn, JH | ko |
dc.contributor.author | Kwon, BM | ko |
dc.date.accessioned | 2013-03-03T22:08:18Z | - |
dc.date.available | 2013-03-03T22:08:18Z | - |
dc.date.created | 2012-02-06 | - |
dc.date.created | 2012-02-06 | - |
dc.date.issued | 2002-06 | - |
dc.identifier.citation | BIOORGANIC MEDICINAL CHEMISTRY LETTERS, v.12, no.12, pp.1599 - 1602 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | http://hdl.handle.net/10203/80657 | - |
dc.description.abstract | The first example of tripeptide inhibitors of farnesyltransferase with sub-micromolar inhibition activity was developed based on the fact that CVFM is not a substrate for farnesyltransferase. (C) 2002 Elsevier Science Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | FARNESYL-PROTEIN TRANSFERASE | - |
dc.subject | ASYMMETRIC-SYNTHESIS | - |
dc.subject | ALPHA-AMINO | - |
dc.subject | ARTEMINOLIDE | - |
dc.subject | ANALOG | - |
dc.subject | DESIGN | - |
dc.title | Development of tripeptidyl farnesyltransferase inhibitors | - |
dc.type | Article | - |
dc.identifier.wosid | 000176178700013 | - |
dc.identifier.scopusid | 2-s2.0-0037124186 | - |
dc.type.rims | ART | - |
dc.citation.volume | 12 | - |
dc.citation.issue | 12 | - |
dc.citation.beginningpage | 1599 | - |
dc.citation.endingpage | 1602 | - |
dc.citation.publicationname | BIOORGANIC MEDICINAL CHEMISTRY LETTERS | - |
dc.contributor.localauthor | Lee, Hee Yoon | - |
dc.contributor.nonIdAuthor | Sohn, JH | - |
dc.contributor.nonIdAuthor | Kwon, BM | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordPlus | FARNESYL-PROTEIN TRANSFERASE | - |
dc.subject.keywordPlus | ASYMMETRIC-SYNTHESIS | - |
dc.subject.keywordPlus | ALPHA-AMINO | - |
dc.subject.keywordPlus | ARTEMINOLIDE | - |
dc.subject.keywordPlus | ANALOG | - |
dc.subject.keywordPlus | DESIGN | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.